Nexus Investment Management’s AbbVie ABBV Stock Holding History

Nexus Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870K	Hold	3,456	–	–	0.11%	32
2026 Q1	$752K	Hold	3,456	–	–	0.11%	33
2025 Q4	$790K	Hold	3,456	–	–	0.11%	31
2025 Q3	$800K	Hold	3,456	–	–	0.11%	30
2025 Q2	$642K	Hold	3,456	–	–	0.1%	32
2025 Q1	$1.04M	Hold	3,456	–	–	0.12%	30
2024 Q4	$614K	Hold	3,456	–	–	0.06%	53
2024 Q3	$682K	Hold	3,456	–	–	0.07%	54
2024 Q2	$593K	Hold	3,456	–	–	0.06%	55
2024 Q1	$629K	Hold	3,456	–	–	0.06%	57
2023 Q4	$536K	Hold	3,456	–	–	0.06%	58
2023 Q3	$515K	Hold	3,456	–	–	0.06%	58
2023 Q2	$466K	Hold	3,456	–	–	0.05%	58
2023 Q1	$551K	Hold	3,456	–	–	0.06%	57
2022 Q4	$559K	Buy	+3,456	New	+$530K	0.06%	55
2014 Q3	–	Sell	-3,900	Closed	-$220K	–	66
2014 Q2	$220K	Hold	3,900	–	–	0.04%	66
2014 Q1	$200K	Sell	3,900 -540	-12%	-$27.3K	0.04%	67
2013 Q4	$234K	Buy	+4,440	New	+$218K	0.05%	65

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Nexus Investment Management's ABBV Position: Q2 2026 in Review

Nexus Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 3,456 shares worth $870K. The position accounts for 0.11% of the portfolio, ranked #32.

Nexus Investment Management first reported a position in ABBV in Q4 2013 and has held it in 18 quarters since. The position peaked at $1.04M in Q1 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Nexus Investment Management held 3,456 shares of AbbVie worth $870K as of Q2 2026.
Nexus Investment Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.11% of Nexus Investment Management's portfolio in Q2 2026, its #32 holding.
Nexus Investment Management first reported a position in AbbVie in Q4 2013 and has held it in 18 quarters since.
Nexus Investment Management's AbbVie position peaked at $1.04M in Q1 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.